UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 231

Sortiert nach

The average body surface area of adult cancer patients in the UK: a multicentre retrospective study

PloS one, 2010-01, Vol.5 (1), p.e8933-e8933

2010

Link zum Volltext

Verfügbarkeit prüfen

Challenges and Strategies in Precision Medicine for Non-Small-Cell Lung Cancer

Current pharmaceutical design, 2016-01, Vol.22 (28), p.4374

2016

Link zum Volltext

Verfügbarkeit prüfen

Emerging roles of deubiquitinases in cancer‐associated pathways

IUBMB life, 2010-02, Vol.62 (2), p.140-157

2010

Link zum Volltext

Verfügbarkeit prüfen

Talimogene laherparepvec upregulates immune-cell populations in non-injected lesions: findings from a phase II, multicenter, open-label study in patients with stage IIIB–IVM1c melanoma

Journal for immunotherapy of cancer, 2021-03, Vol.9 (3), p.e001621

2021

Link zum Volltext

Verfügbarkeit prüfen

The Chick Embryo Xenograft Model for Malignant Pleural Mesothelioma: A Cost and Time Efficient 3Rs Model for Drug Target Evaluation

Cancers, 2022-11, Vol.14 (23), p.5836

2022

Link zum Volltext

Verfügbarkeit prüfen

Exploring the potential of BH3 mimetic therapy in squamous cell carcinoma of the head and neck

Cell death & disease, 2019-12, Vol.10 (12), p.912-10, Article 912

2019

Link zum Volltext

Verfügbarkeit prüfen

Sensitivity and Specificity of Different Prognostic Systems in Guiding Surveillance for Metastases in Uveal Melanoma

Cancers, 2023-05, Vol.15 (9), p.2610

2023

Link zum Volltext

Verfügbarkeit prüfen

Oestrogen Receptor Positive Metastatic Eccrine Porocarcinoma: A Case Report and Review of Anti-Oestrogen Therapy in Rare Cancers

Case reports in oncology, 2024-01, Vol.17 (1), p.497-503

2024

Link zum Volltext

Verfügbarkeit prüfen

Loss of the deubiquitylase BAP1 alters class I histone deacetylase expression and sensitivity of mesothelioma cells to HDAC inhibitors

Oncotarget, 2015-05, Vol.6 (15), p.13757-13771

2015

Link zum Volltext

Verfügbarkeit prüfen

Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma

The New England journal of medicine, 2021-09, Vol.385 (13), p.1196-1206

2021

Link zum Volltext

Verfügbarkeit prüfen

Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma

Journal for immunotherapy of cancer, 2024-06, Vol.12 (6), p.e009028

2024

Link zum Volltext

Verfügbarkeit prüfen

Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development

The Journal of pathology, 2020-04, Vol.250 (4), p.420-439

2020

Link zum Volltext

Verfügbarkeit prüfen

Advances in the clinical management of uveal melanoma

Nature reviews. Clinical oncology, 2023-02, Vol.20 (2), p.99-115

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial

Nature medicine, 2022-11, Vol.28 (11), p.2364-2373

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma

Journal of clinical oncology, 2022-06, Vol.40 (17), p.1939-1948

2022

Link zum Volltext

Verfügbarkeit prüfen

Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma

The New England journal of medicine, 2023-12, Vol.389 (24), p.2256-2266

2023

Link zum Volltext

Verfügbarkeit prüfen

Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs

Nature (London), 2022-05, Vol.605 (7911), p.741-746

2022

Link zum Volltext

Verfügbarkeit prüfen

A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma

European journal of cancer (1990), 2024-05, Vol.202, p.114009-114009, Article 114009

2024

Link zum Volltext

Verfügbarkeit prüfen

Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles

British journal of cancer, 2021-05, Vol.124 (10), p.1661-1669

2021

Link zum Volltext

Verfügbarkeit prüfen

BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Molecular cancer research, 2023-05, Vol.21 (5), p.411-427

2023

Link zum Volltext

Verfügbarkeit prüfen

Genetic variants associated with mandibular osteoradionecrosis following radiotherapy for head and neck malignancy

Radiotherapy and oncology, 2021-12, Vol.165, p.87-93

2021

Link zum Volltext

Verfügbarkeit prüfen

Conjunctival melanoma copy number alterations and correlation with mutation status, tumor features, and clinical outcome

Pigment cell and melanoma research, 2019-07, Vol.32 (4), p.564-575

2019

Link zum Volltext

Verfügbarkeit prüfen

The deubiquitylase USP15 regulates topoisomerase II alpha to maintain genome integrity

Oncogene, 2018-04, Vol.37 (17), p.2326-2342

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 231

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(209)
Mit Volltextzugriff
(202)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

The average body surface area of adult cancer patients in the UK: a multicentre retrospective study

Challenges and Strategies in Precision Medicine for Non-Small-Cell Lung Cancer

Emerging roles of deubiquitinases in cancer‐associated pathways

Talimogene laherparepvec upregulates immune-cell populations in non-injected lesions: findings from a phase II, multicenter, open-label study in patients with stage IIIB–IVM1c melanoma

The Chick Embryo Xenograft Model for Malignant Pleural Mesothelioma: A Cost and Time Efficient 3Rs Model for Drug Target Evaluation

Exploring the potential of BH3 mimetic therapy in squamous cell carcinoma of the head and neck

Sensitivity and Specificity of Different Prognostic Systems in Guiding Surveillance for Metastases in Uveal Melanoma

Oestrogen Receptor Positive Metastatic Eccrine Porocarcinoma: A Case Report and Review of Anti-Oestrogen Therapy in Rare Cancers

Loss of the deubiquitylase BAP1 alters class I histone deacetylase expression and sensitivity of mesothelioma cells to HDAC inhibitors

Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma

Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma

Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development

Advances in the clinical management of uveal melanoma

Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial

Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma

Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma

Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs

A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma

Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles

BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Genetic variants associated with mandibular osteoradionecrosis following radiotherapy for head and neck malignancy

Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study

ASO Visual Abstract: Efficacy and Safety of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter, Phase 3 Study

Conjunctival melanoma copy number alterations and correlation with mutation status, tumor features, and clinical outcome

The deubiquitylase USP15 regulates topoisomerase II alpha to maintain genome integrity

Suchergebnisse filtern